Maternal and perinatal outcomes of sickle cell disease in pregnancy: A nationwide study in France
British Journal of Haematology · 2025-04 · 206 (4) · 1218-1227
DOI: 10.1111/bjh.20009 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 21.02.2025. Verfasst von Alice Corsia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Biotherapy Department and Clinical Investigation Center, Assistance Publique Hôpitaux de Paris, Hôpital Universitaire Necker-Enfants Malades, Paris, …. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Pregnancy Complications, Hematologic. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
This nationwide cohort study provides a comprehensive overview of maternal and perinatal outcomes associated with sickle cell disease (SCD) during pregnancy. Using the French national health database, all singleton pregnancy‐related hospital discharges from 2013 to 2020 in women aged 15–55 ( n = 5 752 080) were selected. Of these, 1022 births were to women with SCD, 308 of whom were on long‐term treatment, that is, hydroxyurea (HU) and/or transfusion programme. Pregnancies with SCD were more likely to involve pre‐eclampsia (9.6% vs. 1.7%; p < 0.001), pulmonary embolism (0.70% vs. 0.02%; p < 0.001), caesarean sections (52.8% vs. 18.2%; p < 0.001) and postpartum haemorrhage (8.3% vs. 4.1%; p < 0.001) compared to pregnancies without SCD. Preterm birth (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biotherapy Department and Clinical Investigation Center, Assistance Publique Hôpitaux de Paris, Hôpital Universitaire Necker-Enfants Malades, Paris, France.
- Centre de référence des syndromes drépanocytaires majeurs, service de Biothérapie, Hôpital Universitaire Necker-Enfants Malades, Université de Paris, Paris, France.
- IMAGINE Institute, Université de Paris, Sorbonne Paris Cité, Paris, France.
- EA7323, Evaluation thérapeutique et pharmacologie périnatale et pédiatrique, Université Paris Cité, Paris, France.
- Unité de Recherche clinique, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.
- Service de Gynécologie Obstétrique, Assistance Publique Hôpitaux de Paris, Hôpital Universitaire Necker-Enfants Malades, Paris, France.
ORCID-Profile: Alice Corsia, Sandra Manceau
Zitieren
APA
Corsia, A., Joseph, L., Beeker, N., Manceau, S., Driessen, M., Meunier, B., Cavazzana, M., Collier, M., & Treluyer, J. M. (2025). Maternal and perinatal outcomes of sickle cell disease in pregnancy: A nationwide study in France. British Journal of Haematology, 206(4), 1218-1227. https://doi.org/10.1111/bjh.20009
Vancouver
Corsia A, Joseph L, Beeker N, Manceau S, Driessen M, Meunier B, et al. Maternal and perinatal outcomes of sickle cell disease in pregnancy: A nationwide study in France. British Journal of Haematology. 2025;206(4):1218-1227. doi:10.1111/bjh.20009
BibTeX
@article{Corsia2025,
author = {Corsia, Alice and Joseph, Laure and Beeker, Nathanael and Manceau, Sandra and Driessen, Marine and Meunier, Benoit and Cavazzana, Marina and Collier, Mathis and Treluyer, Jean-Marc},
title = {Maternal and perinatal outcomes of sickle cell disease in pregnancy: A nationwide study in France},
journal = {British Journal of Haematology},
year = {2025},
volume = {206},
number = {4},
pages = {1218--1227},
doi = {10.1111/bjh.20009}
}
EUVIMED